US Regenerative Medicine Market Growth And Size Report To 2020: Radiant Insights, Inc
Transcription
US Regenerative Medicine Market Growth And Size Report To 2020: Radiant Insights, Inc
US Regenerative Medicine Market Growth And Size Report To 2020: Radiant Insights, Inc Market outlook of the regenerative medicine market in the US Regenerative medicine deals with the process of using therapeutically-induced or laboratory grown human tissue to treat diseased or injured human cells, tissues, or organs. It is an emerging field of treatment that helps in producing new cells to substitute malfunctioning or injured cells as a vehicle to treat disease and injury. The regenerative medicine market can be characterized into three major modalities, namely tissue engineering, biomaterials/biomolecules, and stem cell therapy. This market research analysts expect the regenerative medicine market in the US to grow at a fast pace, posting a remarkable CAGR of more than 33% during the forecast period because of the growing demand for tissue-engineered and stem cell products for the treatment of various diseases. The potential of these medicines in regenerating diseased organs is one of the major factors that drives the market in the US. The stem cells application and advancements in nanotechnology will further drive the progress in this market. Get Full Details On: http://www.radiantinsights.com/research/regenerative-medicine-market-inthe-us-2016-2020 Segmentation by product and analysis of - cell therapy and scaffold Cell therapy helps in treating the diseases or to improving the functioning of the existing cells, by administrating of cells into the body. This therapy addresses medical conditions related to the bone, cartilage, heart, skin, digestive system, reproductive system, eye, blood, spine, brain, and the nervous system. In 2015, cell therapy segment accounted for approximately 80% of the market share. The report offers an analysis of each of the following segments and discusses its impact on the overall market growth Cell therapy Scaffold Segmentation by application and analysis of - dermatology, musculoskeletal, ocular, and cardiovascular The year 2015 saw the precedence of the dermatology segment, accounting for a market share of more than 51%. Dermatology includes the treatment of burns and chronic wounds that requires a quick response, and skin grafting is essential in many cases. Factors such as the increase in obesity and diabetes, growing elderly population, and an increase in life expectancy are some of the causes contributing to the growth of the dermatology market. The report offers an analysis of each of the following segments and discusses its impact on the overall market growth Dermatology Musculoskeletal Ocular Cardiovascular Competitive landscape and key vendors - AkzoNobel, Jotun, PPG Get Full Details On: http://www.radiantinsights.com/research/regenerative-medicine-market-inthe-us-2016-2020 Regenerative medicine market in the US is highly competitive and fragmented because of the presence of several established vendors and this competitive environment is expected to intensify with advances in R&D and technological innovations. International players are likely to acquire regional or local players to enhance their products and expand their market share during the forecast period. The top vendors in the market are Acelity Mesoblast Organogenesis Reprocell Stryker Other prominent vendors include Table of Contents PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Gene therapy: An emerging field in regenerative medicine PART 06: Pipeline portfolio PART 07: Regulatory scenario FDA process PART 08: Market landscape Market overview Market size and forecast Five forces analysis Get Full Details On: http://www.radiantinsights.com/research/regenerative-medicine-market-inthe-us-2016-2020 PART 09: Market segmentation by product Cell therapy Cell therapy market in US Scaffold Scaffold market in US PART 10: Market segmentation by application Dermatology Musculoskeletal Ocular Cardiovascular PART 11: Market drivers Rise in prevalence of chronic diseases Technological innovations Increase in investment for research and development activities PART 12: Impact of drivers PART 13: Market challenges Stringent regulatory approval process Ethical challenges Lack of clinical data PART 14: Impact of drivers and challenges PART 15: Market trends Increase in pipeline products Strategic alliances Potential of regenerative medicine toward decreasing healthcare costs Get Full Details On: http://www.radiantinsights.com/research/regenerative-medicine-market-inthe-us-2016-2020 PART 16: Vendor landscape Competitive scenario Key news Mergers and acquisitions Key vendor analysis 2015 Other prominent vendors PART 17: Key vendor analysis Acelity Mesoblast Organogenesis Reprocell Stryker PART 18: Appendix List of abbreviations PART 19: Explore Technavio ? List of Exhibits Exhibit 01: Product offerings Exhibit 02: Number of ongoing clinical trials Exhibit 03: Gene therapy pipeline products based on indication Exhibit 04: Gene therapy research by sponsorship Exhibit 05: Some of the pipeline products of gene therapy Exhibit 06: Pipeline products of regenerative medicine for cardiovascular diseases Exhibit 07: Pipeline products of regenerative medicine for central nervous system diseases Get Full Details On: http://www.radiantinsights.com/research/regenerative-medicine-market-inthe-us-2016-2020 Exhibit 08: Pipeline products of regenerative medicine for spine and orthopedics diseases Exhibit 09: Pipeline products of regenerative medicine for diabetes and autoimmune diseases Exhibit 10: Overview of number of companies and products of regenerative medicine Exhibit 11: Financial performance of regenerative medicine 2013 and 2014 Exhibit 12: Marketed products of different therapy areas in 2014 Exhibit 13: Regenerative medicine stakeholders Exhibit 14: Guidelines to be followed prior to the initiation of clinical studies for regenerative products Exhibit 15: Regenerative medicine market in US 2015-2020 ($ millions) Exhibit 16: Five forces analysis Exhibit 17: Cell therapy procedure Exhibit 18: Cell therapy market in US 2015-2020 ($ millions) Exhibit 19: Scaffold market in US 2015-2020 ($ millions) Exhibit 20: Segmentation of regenerative medicine market in US 2015-2020 ($ millions) Exhibit 21: Segmentation of regenerative medicine market in US 2015-2020 Exhibit 22: Segmentation of regenerative medicine by application 2015 Exhibit 23: Revenues funded by federal agencies for regenerative medicine research Exhibit 24: Impact of drivers Exhibit 25: Impact of drivers and challenges Exhibit 26: Some of the mid- and late-stage pipeline products for regenerative medicine Exhibit 27: Mesoblast: Key takeaways Exhibit 28: Reprocell: Key takeaways Exhibit 29: Acelity: Key takeaways Exhibit 30: Organogenesis: Key takeaways Exhibit 31: Stryker: Key takeaways Exhibit 32: Acelity: Business segmentation by revenue 2014 Get Full Details On: http://www.radiantinsights.com/research/regenerative-medicine-market-inthe-us-2016-2020 Exhibit 33: Acelity: Business segmentation by revenue 2013 and 2014 Exhibit 34: Acelity: Geographical segmentation by revenue 2014 Exhibit 35: Mesoblast: Product pipeline Exhibit 36: Organogenesis: Product offerings Exhibit 37: Reprocell: Product categories Exhibit 38: Stryker: Business/product segmentation by revenue 2014 Exhibit 39: Stryker: Business segmentation by revenue 2013 and 2014 ($ millions) About Radiant Insights Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. For more information visit, Radiant Insights Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519